Literature DB >> 27647321

Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis.

Yousef Amini1, Bagher Moradi2, Mahdi Fasihi-Ramandi1.   

Abstract

Many materials such as aluminum hydroxide have been tried as adjuvants to compensate low inherent immunogenicity of subunit vaccines. The aim of this study was to evaluate the specific immune response following the administration of aluminum hydroxide nanoparticles with EsxV antigen. The physiochemical properties of the nanoparticle were characterized in vitro. After subcutaneous immunization, cytokine secretion patterns including IFN-gama,IL-4, and TGF-beta levels were measured by indirect enzyme linked immunosorbent assay (ELISA). Aluminum hydroxide-NPs were demonstrated excellent effects to raise of IFN-γ secretion in compare to EsxV alone. Administration of aluminum hydroxide nanoparticles stimulates strong cellular immune response and could be considered as appropriate adjuvant against TB infection.

Entities:  

Keywords:  EsxV; Tuberculosis; aluminum hydroxide; immune response; nanoparticles

Mesh:

Substances:

Year:  2016        PMID: 27647321     DOI: 10.1080/21691401.2016.1233111

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  4 in total

Review 1.  Aluminium Nanoparticles as Efficient Adjuvants Compared to Their Microparticle Counterparts: Current Progress and Perspectives.

Authors:  Ali Nazarizadeh; Alexander H Staudacher; Nicole L Wittwer; Tyron Turnbull; Michael P Brown; Ivan Kempson
Journal:  Int J Mol Sci       Date:  2022-04-24       Impact factor: 6.208

2.  Immunogenicity profile in African green monkeys of a vaccine candidate based on a mutated form of human Interleukin-15.

Authors:  Yunier Rodríguez-Álvarez; Lino Gerardo Batista-Roche; Alexey Llopiz-Arzuaga; Pedro Puente-Pérez; Rafael Martínez-Castillo; Jorge Castro-Velazco; Alicia Santos-Savio
Journal:  BMC Immunol       Date:  2021-12-18       Impact factor: 3.615

Review 3.  Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action.

Authors:  Emma Shardlow; Matthew Mold; Christopher Exley
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-07       Impact factor: 3.406

4.  Immunogenicity of glycine nanoparticles containing a chimeric antigen as Brucella vaccine candidate.

Authors:  Ghazal Karevan; Kazem Ahmadi; Ramezan Ali Taheri; Mahdi Fasihi-Ramandi
Journal:  Clin Exp Vaccine Res       Date:  2021-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.